Abstract
Crude extracts of Dracaena steudneri bark (DSB), Sapium ellipticum bark (SEB) and Capparis erythrocarpos root (CER) were investigated for their antifungal activity in immunocompromised mice infected with Candida albicans in an in vivo mice infection model. Extracts of these plant species are commonly used to treat fungal infections in East African countries. Three groups of white albino mice were immunosuppressed with 200 mg/kg body weight of cyclophosmamide for four consecutive days after which they were administered with 0.3 ml of 0.5 McFarland standard inoculum of C. albicans. The groups were treated with escalating doses of 100, 200 and 400 mg/kg of body weight of dichloromethane extracts. There was substantial dose dependency in all treatments given, with mice survival to the end of the experiment correlating well to the dose levels. At a dose of 400 mg/kg, C. erythrocarpos was the most effective with mice survival of 60% and organ burden clearance ranging from 64.0%–99.9% (P < 0.0001) in all treatments. The results revealed that C. erythrocarpos possessed significant potential for development into antifungal drugs suitable for control of Candida infections. The effectiveness of the plant extracts in vivo was a confirmation of the value of ethnopharmacological leads in drug discovery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad A, Husain A, Mujeeb M, Khan A, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F (2013) A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac J Trop Biomed 3(5):337–352
Ara N, Nur MH, Amran MS, Wahid MII, Ahmed M (2009) In vitro antimicrobial and cytotoxic activities of leaves and flower extracts from Lippia alba. Pak J Biol Sci 12(1):87–90
Blignaut E (2007) Oral candidiasis and oral yeast carriage among institutionalized South African paedriatic HIV/AIDS patients. Mycopathologia 163:67–73
Chinchilla M, Guerrero OM, Abarca G, Barrios M, Castro O (1998) An in vivo model to study the anti-malaric capacity of plant extracts. Int J Trop Biol 46:35–39
Clark JM, Whitney RR, Olsen SJ, George RJ, Swerdel MR, Kunselman L, Bonner DP (1991) Amphotericin B Lipid Complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother 35:615–621
De Toledo CEM, Britta EA, Ceole LF, Silva ER, De Mello JCP, Filh BPD (2011) Antimicrobial and cytotoxic activities of medicinal plants of the Brazilian cerrado, using Brazilian cachac, as an extractor liquid. J Ethnopharmacol 133(2):420–425
Diwan PV (2006) In vivo efficacy of an antifungal fraction from Pallavicinia lyellii, a liverwort. Indian J Pharm 38(3):211–212
Dogan A, Ergen K, Budak F, Severcan F (2007) Evaluation of Disseminated Candidiasis on an Experimental Animal Model: A Fourier Transform Infrared Study. Appl Spectrosc 61(2):199–203
Ernst E (2001) The desktop guide to complementary and alternative medicine: an evidence-based approach. J Roy Soc Med 94:650–651
Kisangau DP, Hosea KM, Lyaruu HVM, Joseph CC, Mbwambo ZH, Masimba PJ, Gwandu CB, Bruno LN, Devkota KP, Sewald N (2009) Screening of traditionally used Tanzanian medicinal plants for antifungal activity. Int J Pharmaceut Biol 47(8):708–716
Marianne D, Ronald A, Froyen G, Frank CO, Fermin S, Roland C, Walter HMLL (2000) Single allele knock-out of Candida albicans CGT1 leads to unexpected resistance to hygromycin B and elevated temperature. Microbiologica 46:353–365
Masoko P, Eloff JN (2005) The diversity of antifungal compounds of six South African Terminalia species (Combretaceae) determined by bioautography. Afr J Biotechnol 4(12):1425–1431
Masuoka J (2004) Surface Glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 17(2):281–310
Moussa A, Noureddine D, Saad A, Abdelmalek A, Salima B (2012) The mixture of natural honey and Peganum harmala seeds against Candida albicans by well diffusion method. Asian Pac J Trop Biomed 6:1–4
Rekha S, Vidyasagar GM (2013) Anti-Candida activity of medicinal plants. A review. Int J Pharm Pharm Sci 5(14):9–16
Runyoro DKB, Matee MIN, Ngassapa OD, Joseph CC, Mbwambo ZH (2006) Screening of Tanzanian medicinal plants for anti-Candida activity. BMC Compl Altern Med 6:11
Scorzoni L, Benaducci T, Almeida AMF, Silva DHS, Bolzani VS, Gianinni MJSM (2007) The use of standard methodology for determination of antifungal activity of natural products against medical yeasts Candida sp and Cryptococcus sp. Braz J Microbiol 38:1–12
Tabosa Do Egito ES, Appel M, Fessi H, Barrett G, Puisieux F, Devissaguet J (1996) In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system. J Antimicrob Chemother 38(3):485–497
Warn P, Denning DW (1999) Dose range evaluation of Liposomal Nystatin and comparisons with Amphotericin B and Amphotericin B Lipid Complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to Amphotericin B. Antimicrob Agents Chemother 43(11):2592–2599
Warn PA, Morrissey J, Moore CB, Denning DW (2000) In-vivo activity of amphotericin B Lipid complex in immunocompromised mice against Fluconazole-resistante or Fluconazole-susceptible Candida tropicalis. Antimicrob Agents Chemother 44(10):2664–2671
Warn PA, Sharp A, Morrissey G, Denning DW (2005) Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis. Antimicrob Agents Chemother 56:590–593
You X, Li C, Yang X, Yuan M, Zhang W, Lou R, Wang Y, Li G, Chen H, Song D, Sun C, Cen S, Yu L, Zhao L, Jiang J (2009) In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother 53(10):4525–4528
Acknowledgments
We are grateful to DAAD/NAPRECA, the Inter-University Council of East Africa Research initiative (VicRes) and the International Foundation for Science (IFS) for financial support to carry out this work. We thank Messrs. F.M. Mbago and S. Haji of the Herbarium, Botany department, University of Dar es Salaam for identifying the plant species used in this study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Kisangau, D.P., Hosea, K.M., Lyaruu, H.V.M., Josep, C.C., Mbwambo, Z.H., Masimba, P.J. (2017). In vivo Anticandida Activity of Three Traditionally Used Medicinal Plants in East Africa. In: Neffati, M., Najjaa, H., Máthé, Á. (eds) Medicinal and Aromatic Plants of the World - Africa Volume 3. Medicinal and Aromatic Plants of the World, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1120-1_14
Download citation
DOI: https://doi.org/10.1007/978-94-024-1120-1_14
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-1119-5
Online ISBN: 978-94-024-1120-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)